-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Receives Two Prestigious Awards from the All-China Federation of Industry and Commerce’s Chamber of Commerce for the Pharmaceutical Industry
Category:
发布时间：2023-03-27
【概要描述】
On March 26, the Annual Summit of the All-China Federation of Industry and Commerce Pharmaceutical Chamber of Commerce, together with the Qingdao High-tech Industrial Development Zone Management Committee and the Qingdao Municipal Federation of Industry and Commerce, convened in Qingdao for the National Federation of Industry and Commerce Pharmaceutical Chamber of Commerce Annual Summit and the Qingdao High-tech Zone Biopharmaceutical Industry Promotion Conference. During the event, the Chamber unveiled a series of prestigious rankings for the 2021–2022 period, including the “Most Influential Companies in China’s Pharmaceutical Industry.” Shijiazhuang Sihua Pharmaceutical Group was honored with two distinguished accolades: “Top 100 Chinese Pharmaceutical Manufacturers” and “Pioneer Enterprise for Independent Innovation in China’s Pharmaceutical Industry.”
On March 26, the Annual Summit of the All-China Federation of Industry and Commerce Pharmaceutical Chamber of Commerce, together with the Qingdao High-tech Industrial Development Zone Management Committee and the Qingdao Municipal Federation of Industry and Commerce, convened in Qingdao for the National Federation of Industry and Commerce Pharmaceutical Chamber of Commerce Annual Summit and the Qingdao High-tech Zone Biopharmaceutical Industry Promotion Conference. During the event, the Chamber unveiled a series of prestigious rankings for the 2021–2022 period, including the “Most Influential Companies in China’s Pharmaceutical Industry.” Shijiazhuang Sihua Pharmaceutical Group was honored with two distinguished accolades: “Top 100 Chinese Pharmaceutical Manufacturers” and “Pioneer Enterprise for Independent Innovation in China’s Pharmaceutical Industry.”
In recent years, Shijiazhuang Sihua Pharmaceutical Group has fully leveraged its strengths, aligning its innovation efforts with the industrial value chain and accelerating the development of specialty generic drugs, innovative medicines, active pharmaceutical ingredients, and pharmaceutical packaging materials. A phased, tiered innovation model—“develop a batch, translate a batch, and stockpile a batch”—has gradually taken shape, enabling synchronized progress across the entire drug R&D-to-market translation value chain. Continuous optimization of the product portfolio and steady enhancement of the company’s development capabilities have effectively propelled corporate performance improvement and efficiency gains, elevating the enterprise to the mid- to high-end segments of the value chain.
According to reports, the 2021–2022 China Pharmaceutical Industry Most Influential Rankings were compiled by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, using performance metrics, indigenous innovation capacity, social responsibility index, and level of professionalization as key evaluation criteria. To date, the ranking has been held for nine consecutive years, with the aim of fostering the development of the pharmaceutical industry and amplifying the strongest voices of influence for the winning companies and entrepreneurs. With its comprehensive coverage of the entire industrial chain, strong representativeness, and high level of participation, the event has become one of the most authoritative branding initiatives in China’s pharmaceutical sector, garnering widespread attention from industry players and business leaders alike.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091